CoChat

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges

Open access
Parrotta, Elvira Immacolata, Lucchino, Valeria, Scaramuzzino, Luana, Scalise, Stefania, Cuda, Giovanni · 2020 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.

Abstract

Cardiovascular diseases (CVDs) are a class of disorders affecting the heart or blood vessels. Despite progress in clinical research and therapy, CVDs still represent the leading cause of mortality and morbidity worldwide. The hallmarks of cardiac diseases include heart dysfunction and cardiomyocyte death, inflammation, fibrosis, scar tissue, hyperplasia, hypertrophy, and abnormal ventricular remodeling. The loss of cardiomyocytes is an irreversible process that leads to fibrosis and scar formation, which, in turn, induce heart failure with progressive and dramatic consequences. Both genetic and environmental factors pathologically contribute to the development of CVDs, but the precise causes that trigger cardiac diseases and their progression are still largely unknown. The lack of reliable human model systems for such diseases has hampered the unraveling of the underlying molecular mechanisms and cellular processes involved in heart diseases at their initial stage and during their progression. Over the past decade, significant scientific advances in the field of stem cell biology have literally revolutionized the study of human disease in vitro. Remarkably, the possibility to generate disease-relevant cell types from induced pluripotent stem cells (iPSCs) has developed into an unprecedented and powerful opportunity to achieve the long-standing ambition to investigate human diseases at a cellular level, uncovering their molecular mechanisms, and finally to translate bench discoveries into potential new therapeutic strategies. This review provides an update on previous and current research in the field of iPSC-driven cardiovascular disease modeling, with the aim of underlining the potential of stem-cell biology-based approaches in the elucidation of the pathophysiology of these life-threatening diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21124354

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Advantages of induced pluripotent stem cells (iPSCs) over mutant embryonic stem cells(ESCs) and genetically modified mouse models.
Figure 1 Advantages of induced pluripotent stem cells (iPSCs) over mutant embryonic stem cells(ESCs) and genetically modified mouse models.CC BY · PubMed Central
Figure 2 Major applications of iPSCs in research and medicine.
Figure 2 Major applications of iPSCs in research and medicine.CC BY · PubMed Central
Figure 3 Application of genome-editing tools in human iPSC technology.
Figure 3 Application of genome-editing tools in human iPSC technology.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 90

Metadata

Authors
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G.
Affiliations
Magna Graecia University (IT)
Corresponding author
Parrotta, Elvira Immacolata
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-06-19
Volume
21
Issue
12
Pages
4354
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3036591244
Cited by
88
References
212
Citations by year
2026: 6 · 2025: 17 · 2024: 19 · 2023: 15 · 2022: 12 · 2021: 17 · 2020: 2
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
induced pluripotent stem cells, iPSC-derived cardiomyocytes, cardiovascular disease modeling, cardiomyocyte death, myocardial fibrosis, heart failure, ventricular remodeling, cardiomyocyte hypertrophy, cardiomyocyte hyperplasia, cardiac inflammation, disease pathophysiology, stem cell therapy
MeSH terms
Cell Differentiation, Heart Diseases, Humans, Models, Biological, Signal Transduction, Disease Progression, Myocytes, Cardiac, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.